Stanley Cohen Archive — Page 1 of 1

Stanley Cohen, PhD, gestures while speaking to a seated audience in front of a whiteboard.
November 21, 2024

Ken Lau and Eunyoung Choi named 2024 Stanley Cohen Innovation Fund awardees

Older man with gray hair smiling while seated indoors, wearing a blue plaid shirt.
September 14, 2022

Hodges, Nakagawa receive Cohen Innovation funds

Emily Hodges, PhD, assistant professor of Biochemistry, and Terunaga Nakagawa, MD, PhD, associate professor of Molecular Physiology and Biophysics, were named as the 2022 recipients of Stanley Cohen Innovation Funds

Cody Siciliano, PhD, is studying the neural substrates of memory.
September 24, 2020

Cohen Fund bolsters Siciliano’s memory research

Cody Siciliano, PhD, assistant professor of Pharmacology in the Vanderbilt University School of Medicine, has been selected to receive a one-year, $100,000 research award from the Stanley Cohen Innovation Fund to support his studies of the neural substrates of memory.

Black-and-white photograph of Stanley Cohen seated at a cluttered laboratory desk, holding a pipette and a sheet of paper among notebooks, containers, and lab equipment.
February 7, 2020

The elusive Nobel Prize winner

Stanley Cohen wanted to be left alone to do his research. I wanted to interview him for a radio show. Amazingly, he said yes.

Older man with gray hair smiling while seated indoors, wearing a blue plaid shirt.
February 6, 2020

Nobel Prize-winning biochemist Stanley Cohen dies at 97

Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.

A researcher in a white lab coat sits in a laboratory, with shelves of supplies and scientific equipment behind him.
October 12, 2017

Researcher targets peanut allergies with Cohen Fund support

Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith’s research could fundamentally change allergy treatment.